05/18/2026
NEWS: LambdaVision is partnering with Helogen Corporation to advance the future of scalable biomaterial manufacturing in low-Earth orbit.
This mission will mark LambdaVision’s first planned flight outside of the International Space Station and represents an important next step toward regulated, scalable production of our protein-based artificial retina in space.
Through 9 missions to the ISS, LambdaVision has demonstrated the feasibility of manufacturing 200-layer protein thin films in microgravity, where reduced gravity improves homogeneity, stability, and performance.
The collaboration with Helogen grew out of conversations initiated through Boryung’s Humans in Space challenge in 2023, highlighting the importance of building a global ecosystem to advance space-enabled healthcare and biotechnology innovation.
Read the full announcement: https://www.lambdavision.com/lambdavision-and-helogen-partner-to-advance-space-based-biomaterial-manufacturing/